Isothiocyanate derivatives of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]-carbazole (rimcazole):: Irreversible ligands for the dopamine transporter

被引:25
作者
Husbands, SM
Izenwasser, S
Loeloff, RJ
Katz, JL
Bowen, WD
Vilner, BJ
Newman, AH
机构
[1] NIDA, Psychobiol Sect, Intramural Res Program, Baltimore, MD 21224 USA
[2] NIDDK, Med Chem Lab, Bethesda, MD 20892 USA
关键词
D O I
10.1021/jm9705519
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cocaine has been reported to bind to the dopamine transporter in a biphasic fashion, and it has been hypothesized that the low-affinity component may play a modulatory role in cocaine's psychomotor stimulant effects. In an effort to gain further insight into the roles of the two sites, we have prepared a series of irreversible ligands based on rimcazole (9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]carbazole, 2), a compound that has been postulated to bind only to the low-affinity site. The alkylating moiety (isothiocyanate) is attached to the distal nitrogen of the piperazine ring via alkyl chains of varying lengths or directly attached to one of the aromatic groups. It was found that substitution on the piperazine nitrogen caused an initial decrease in affinity that was recovered as the alkyl chain length increased. Importantly, the analogue 16, with the highest affinity for the dopamine transporter (DAT), binds in a monophasic and irreversible manner, as evidenced by the greatly diminished binding of [H-3]WIN 35,428 in tissue that had been preincubated with the Ligand and then thoroughly washed using centrifugation. The dose-dependent reduction in B-max was accompanied by a concentration-related decrease in K-D values. This shift in K-D to a lower value suggests that the preincubation with 16 produced a preferential irreversible binding to the low-affinity [H-3]WIN 35,428 site on the dopamine transporter. These Ligands may prove to be important tools with which to study the significance of the low-affinity site on the DAT. Since rimcazole does not share the behavioral profile of cocaine, and in fact appears to play a modulatory role, these compounds may provide leads for a novel cocaine-abuse treatment.
引用
收藏
页码:4340 / 4346
页数:7
相关论文
共 24 条
[11]   COCAINE AND SEVERAL SIGMA-RECEPTOR LIGANDS INHIBIT DOPAMINE UPTAKE IN RAT CAUDATE-PUTAMEN [J].
IZENWASSER, S ;
NEWMAN, AH ;
KATZ, JL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 243 (02) :201-205
[12]   THE COCAINE ANALOG WIN 35,428 BINDS TO 2 SITES IN FRESH RAT CAUDATE-PUTAMEN - SIGNIFICANCE OF ASSAY PROCEDURES [J].
IZENWASSER, S ;
ROSENBERGER, JG ;
COX, BM .
LIFE SCIENCES, 1993, 52 (16) :PL141-PL145
[13]   (I-125)IODOAZIDOCOCAINE, A PHOTOAFFINITY LABEL FOR THE HALOPERIDOL-SENSITIVE SIGMA-RECEPTOR [J].
KAHOUN, JR ;
RUOHO, AE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (04) :1393-1397
[15]   Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) [J].
Matecka, D ;
Rothman, RB ;
Radesca, L ;
deCosta, BR ;
Dersch, CM ;
Partilla, JS ;
Pert, A ;
Glowa, JR ;
Wojnicki, FHE ;
Rice, KC .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (24) :4704-4716
[16]   Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures [J].
Mello, NK ;
Negus, SS .
NEUROPSYCHOPHARMACOLOGY, 1996, 14 (06) :375-424
[17]   SELECTIVE SIGMA-LIGANDS BLOCK STIMULANT EFFECTS OF COCAINE [J].
MENKEL, M ;
TERRY, P ;
PONTECORVO, M ;
KATZ, JL ;
WITKIN, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 201 (2-3) :251-252
[18]   LIGAND - A VERSATILE COMPUTERIZED APPROACH FOR CHARACTERIZATION OF LIGAND-BINDING SYSTEMS [J].
MUNSON, PJ ;
RODBARD, D .
ANALYTICAL BIOCHEMISTRY, 1980, 107 (01) :220-239
[19]   NOVEL IRREVERSIBLE LIGANDS SPECIFIC FOR PERIPHERAL TYPE BENZODIAZEPINE RECEPTORS - (+/-) , (+) , AND (-)-1-(2-CHLOROPHENYL)-N-(1-METHYLPROPYL)-N-(2-ISOTHIOCYANATOETHYL)-3-ISOQUINOLINECARBOXAMIDE AND 1-(2-ISOTHIOCYANATOETHYL)-7-CHLORO-1,3-DIHYDRO-5-(4-CHLOROPHENYL)-H-2-1,4-BENZODIAZEPIN-2-ONE [J].
NEWMAN, AH ;
LUEDDENS, HWM ;
SKOLNICK, P ;
RICE, KC .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (10) :1901-1905
[20]  
NEWMAN AH, 1990, ANNU REP MED CHEM, V25, P271